Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-19

FDA Approved: LETROZOLE — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Accord Healthcare's generic letrozole, confirming regulatory approval of the generic aromatase inhibitor for breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)